Asset Sadhu
Funds/Sectoral / Thematic/Mirae Asset Healthcare Fund

Mirae Asset Healthcare Fund

Mirae Asset Mutual Fund·Sectoral / Thematic·vs Nifty 500 TRI

The fund maintains a concentrated bet on pharma exporters and domestic formulation players, with Sun Pharma and Divi's anchoring nearly one-fifth of assets. The 76% pharmaceutical skew reflects conviction in margin recovery and currency tailwinds, while the modest healthcare services allocation (22%) provides defensive balance through hospital chains. The exit of Sagility and uptick in Max Healthcare suggest the manager is rotating toward capital-light, higher-margin healthcare delivery models over contract research exposure.

Portfolio analysis · April 2026

PlanNAV1M3M6M1Y3Y CAGR5Y CAGR
Regular Growth₹41.3580+8.28%+9.83%+6.50%+12.91%+25.47%+14.61%
Direct IDCW₹28.1020
Regular IDCW₹24.3470
Returns above 1Y are CAGR. Direct plan rows highlighted. NAV from AMFI.
Holdings
33
Top 5 Weight
39.44%
Top 10 Weight
60.43%
Active Share
Large Cap
36.42%
Gini
0.452
Holdings: 3635+0 added1 removed23 weight shifts ≥ 0.1%
StockWeight
No new entries this month
#Holding% to NAV
1
Sun Pharmaceutical Industries Ltd.
INE044A01036
11.76%
2
Divi's Laboratories Ltd.
INE361B01024
8.23%
3
Glenmark Pharmaceuticals Ltd.
INE935A01035
7.12%
4
JB Chemicals & Pharmaceuticals Ltd.
INE572A01036
6.39%
5
Apollo Hospitals Enterprise Ltd.
INE437A01024
5.93%
6
Lupin Ltd.
INE326A01037
4.57%
7
Dr. Reddy's Laboratories Ltd.
INE089A01031
4.44%
8
Aurobindo Pharma Ltd.
INE406A01037
4.22%
9
Fortis Healthcare Ltd.
INE061F01013
4.06%
10
Laurus Labs Ltd.
INE947Q01028
3.70%
11
Alkem Laboratories Ltd.
INE540L01014
3.51%
12
Krishna Institute of Medical Sciences Ltd.
INE967H01025
3.28%
13
Aster DM Healthcare Ltd.
INE914M01019
3.23%
14
Onesource Specialty Pharma Ltd.
INE013P01021
3.22%
15
Cipla Ltd.
INE059A01026
3.16%
16
Sai Life Sciences Ltd.
INE570L01029
3.13%
17
IPCA Laboratories Ltd.
INE571A01038
3.03%
18
Eris Lifesciences Ltd.
INE406M01024
2.96%
19
Max Healthcare Institute Ltd.
INE027H01010
2.43%
20
Dr. Lal Path labs Ltd.
INE600L01024
1.99%
Pharmaceuticals & Biotechnology76.1%
Healthcare Services22.2%
Chemicals & Petrochemicals1.6%

Top 10 sectors by % to NAV. Excludes derivatives.